v3.26.1
Document And Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2025
Mar. 24, 2026
Jun. 27, 2025
Document Information [Line Items]      
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Document Transition Report false    
Entity File Number 001-12934    
Entity Registrant Name ImmuCell Corporation    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 01-0382980    
Entity Address, Address Line One 56 Evergreen Drive    
Entity Address, City or Town Portland    
Entity Address, State or Province ME    
Entity Address, Postal Zip Code 04103    
City Area Code 207    
Local Phone Number 878-2770    
Title of 12(b) Security Common Stock, $0.10 par value per share    
Trading Symbol ICCC    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 50,600,000
Entity Common Stock, Shares Outstanding (in shares)   9,046,799  
Amendment Description ImmuCell Corporation (the “Company”) is filing this Amendment No. 1 to the Annual Report on Form 10-K (this “Amendment”) to amend the Exhibit List which constitutes a portion of Part IV, Item 15 of its Annual Report on Form 10-K for the year ended December 31, 2025, originally filed with the Securities and Exchange Commission (“SEC”) on March 30, 2026 (the “Original Filing”).    
Entity Central Index Key 0000811641    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Amendment Flag true